{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-017634","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2024-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.357585+00:00","generated_at":"2026-06-05T09:42:35.668377+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"60 Degrees Pharma receives Nasdaq bid price deficiency notice; 180-day cure period","bullets":["Nasdaq notified SXTP that common stock failed to maintain $1.00 minimum bid price for 31 consecutive business days through Feb 27, 2024.","Company has 180 calendar days, until August 26, 2024, to regain compliance with the Bid Price Rule.","If non-compliant by Aug 26, Company may be eligible for additional 180-day period if it meets other listing standards.","Company is evaluating options; there is no immediate effect on listing of SXTP or SXTPW on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-017634","json":"https://secwatch.observer/filing/0001213900-24-017634.json","markdown":"https://secwatch.observer/filing/0001213900-24-017634.md","text":"https://secwatch.observer/filing/0001213900-24-017634.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024017634/0001213900-24-017634-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024017634/ea0200827-8k_60degree.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T09:42:35.668377+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f4fd4082694372c67b8da2b66fa938e11422bbe4","claim":"60 DEGREES PHARMACEUTICALS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"n stating that for the 31 consecutive business day period between January 11, 2024 through February 27, 2024, the common stock of the Company had not maintained a minimum closing bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until August 26, 2024 (the “Compliance Period”), to regain compliance with the Bid Price Rule. If the Company does not regain compliance with the Bid","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024017634/0001213900-24-017634-index.htm","confidence":0.98,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}